Supplementary Figure 5 from E2F8 Contributes to Human Hepatocellular Carcinoma Via Regulating Cell Proliferation

Qi Deng,Qun Wang,Wei-Ying Zong,Duo Zheng,Wen Yao,Kesheng Wang,Xiaochun Teng,Xin Zhang,Jikun Huang,Ze‐Guang Han

DOI: https://doi.org/10.1158/0008-5472.22383686

2023-01-01

Abstract:Supplementary Figure 5 from E2F8 Contributes to Human Hepatocellular Carcinoma via Regulating Cell Proliferation

What problem does this paper attempt to address?

Supplementary Figure 6 from E2F8 Contributes to Human Hepatocellular Carcinoma Via Regulating Cell Proliferation

Qi Deng,Qun Wang,Wei-Ying Zong,Duo Zheng,Wen Yao,Kesheng Wang,Xiaochun Teng,Xin Zhang,Jikun Huang,Ze‐Guang Han

DOI: https://doi.org/10.1158/0008-5472.22383683

2023-01-01

Abstract:Supplementary Figure 6 from E2F8 Contributes to Human Hepatocellular Carcinoma via Regulating Cell Proliferation
Supplementary Figure 7 from E2F8 Contributes to Human Hepatocellular Carcinoma Via Regulating Cell Proliferation

Qi Deng,Qun Wang,Wei-Ying Zong,Duo Zheng,Wen Yao,Kesheng Wang,Xiaochun Teng,Xin Zhang,Jikun Huang,Ze‐Guang Han

DOI: https://doi.org/10.1158/0008-5472.22383680

2023-01-01

Abstract:Supplementary Figure 7 from E2F8 Contributes to Human Hepatocellular Carcinoma via Regulating Cell Proliferation
Supplementary Figure 4 from E2F8 Contributes to Human Hepatocellular Carcinoma Via Regulating Cell Proliferation

Qing Deng,Qun Wang,Wei-Ying Zong,Da-Li Zheng,Yi-Xin Wen,Ke-Sheng Wang,Xiao-Mei Teng,Xin Zhang,Jian Huang,Ze-Guang Han

DOI: https://doi.org/10.1158/0008-5472.22383692.v1

2023-01-01

Abstract:Supplementary Figure 4 from E2F8 Contributes to Human Hepatocellular Carcinoma via Regulating Cell Proliferation
Supplementary Figure 3 from E2F8 Contributes to Human Hepatocellular Carcinoma via Regulating Cell Proliferation

Qing Deng,Qun Wang,Wei-Ying Zong,Da-Li Zheng,Yi-Xin Wen,Ke-Sheng Wang,Xiao-Mei Teng,Xin Zhang,Jian Huang,Ze-Guang Han

DOI: https://doi.org/10.1158/0008-5472.22383695.v1

2023-01-01

Abstract:Supplementary Figure 3 from E2F8 Contributes to Human Hepatocellular Carcinoma via Regulating Cell Proliferation
Supplementary Figure Legends 1-7 from E2F8 Contributes to Human Hepatocellular Carcinoma Via Regulating Cell Proliferation

Qi Deng,Qun Wang,Wei-Ying Zong,Duo Zheng,Wen Yao,Kesheng Wang,Xiaochun Teng,Xin Zhang,Jikun Huang,Ze‐Guang Han

DOI: https://doi.org/10.1158/0008-5472.22383677.v1

2023-01-01

Abstract:Supplementary Figure Legends 1-7 from E2F8 Contributes to Human Hepatocellular Carcinoma via Regulating Cell Proliferation
Supplementary Tables 1-2 from E2F8 Contributes to Human Hepatocellular Carcinoma via Regulating Cell Proliferation

Qing Deng,Qun Wang,Wei-Ying Zong,Da-Li Zheng,Yi-Xin Wen,Ke-Sheng Wang,Xiao-Mei Teng,Xin Zhang,Jian Huang,Ze-Guang Han

DOI: https://doi.org/10.1158/0008-5472.22383674.v1

2023-01-01

Abstract:Supplementary Tables 1-2 from E2F8 Contributes to Human Hepatocellular Carcinoma via Regulating Cell Proliferation
Data from E2F8 Contributes to Human Hepatocellular Carcinoma via Regulating Cell Proliferation

Qing Deng,Qun Wang,Wei-Ying Zong,Da-Li Zheng,Yi-Xin Wen,Ke-Sheng Wang,Xiao-Mei Teng,Xin Zhang,Jian Huang,Ze-Guang Han

DOI: https://doi.org/10.1158/0008-5472.c.6500636.v1

2023-01-01

Abstract:AbstractThe E2F family member of transcription factors includes the atypical member E2F8, which has been little studied in cancer. We report that E2F8 is strongly upregulated in human hepatocellular carcinoma (HCC), where it was evidenced to contribute to oncogenesis and progression. Ectopic overexpression of E2F8 promoted cell proliferation, colony formation, and tumorigenicity, whereas E2F8 knockdown inhibited these phenotypes, as documented in Huh-7, Focus, Hep3B, and YY-8103 HCC cell lines. Mechanistic analyses indicated that E2F8 could bind to regulatory elements of cyclin D1, regulating its transcription and promoting accumulation of S-phase cells. Together, our findings suggest that E2F8 contributes to the oncogenic potential of HCC and may constitute a potential therapeutic target in this disease. Cancer Res; 70(2); 782–91
Supplementary Methods, Figures 1-4 from Rho Kinase Phosphorylation Promotes Ezrin-Mediated Metastasis in Hepatocellular Carcinoma

Yong Chen,Dongmei Wang,Zhen Guo,Jun Zhao,Bing Wu,Hui Deng,Ti Zhou,Hongjun Xiang,Fei Gao,Xue Yu,Jian Liao,Tarsha Ward,Peng Xia,Chibuzo Emenari,Xia Ding,Winston Thompson,Kelong Ma,Jingde Zhu,Felix Aikhionbare,Kefen Dou,Shi-Yuan Cheng,Xuebiao Yao

DOI: https://doi.org/10.1158/0008-5472.22387211

2023-01-01

Abstract:Supplementary Methods, Figures 1-4 from Rho Kinase Phosphorylation Promotes Ezrin-Mediated Metastasis in Hepatocellular Carcinoma
Supplementary Figure from HMGN5 Escorts Oncogenic STAT3 Signaling by Regulating the Chromatin Landscape in Breast Cancer Tumorigenesis

Jiahui Mou,Meijun Huang,Feifei Wang,Xiaoding Xu,Hanqi Xie,Henglei Lu,Mingyang Li,Yu Li,Weiwen Kong,Jing Chen,Ying Xiao,Yiding Chen,Chaochen Wang,Jin Ren

DOI: https://doi.org/10.1158/1541-7786.22527890

2023-01-01

Abstract:Supplementary Figure from HMGN5 Escorts Oncogenic STAT3 Signaling by Regulating the Chromatin Landscape in Breast Cancer Tumorigenesis
Supplementary Methods, Figures 1-9, Tables 2-6 from EZH2-Mediated Concordant Repression of Wnt Antagonists Promotes Β-Catenin–dependent Hepatocarcinogenesis

Alfred S.L. Cheng,Suki S. Lau,Yangchao Chen,Yutaka Kondo,May S. Li,Hai Feng,Arthur K. Ching,Kin F. Cheung,Hoi K. Wong,Joanna H. Tong,Hongchuan Jin,Kwong W. Choy,Jun Yu,Ka F. To,Nathalie Wong,Tim H.-M. Huang,Joseph J.Y. Sung

DOI: https://doi.org/10.1158/0008-5472.22395239.v1

2023-01-01

Abstract:Supplementary Methods, Figures 1-9, Tables 2-6 from EZH2-Mediated Concordant Repression of Wnt Antagonists Promotes β-Catenin–Dependent Hepatocarcinogenesis
Supplementary Data from HBx-Induced HSPA8 Stimulates HBV Replication and Suppresses Ferroptosis to Support Liver Cancer Progression

Yufei Wang,Man Zhao,Lina Zhao,Yu Geng,Guanghao Li,Lin Chen,Jingxuan Yu,Hongfeng Yuan,Huihui Zhang,Haolin Yun,Ying Yuan,Guowen Wang,Jinyan Feng,Liang Xu,Shuai Wang,Chunyu Hou,Guang Yang,Ningning Zhang,Wei Lu,Xiaodong Zhang

DOI: https://doi.org/10.1158/0008-5472.22433561.v1

2023-01-01

Abstract:Supplementary materials and methods, Supplementary figures, Supplementary figure legends, Supplementary tables
Supplementary Table 7 from EZH2-Mediated Concordant Repression of Wnt Antagonists Promotes Β-Catenin–dependent Hepatocarcinogenesis

Alfred S.L. Cheng,Suki S. Lau,Yangchao Chen,Yutaka Kondo,May S. Li,Hai Feng,Arthur K. Ching,Kin F. Cheung,Hoi K. Wong,Joanna H. Tong,Hongchuan Jin,Kwong W. Choy,Jun Yu,Ka F. To,Nathalie Wong,Tim H.-M. Huang,Joseph J.Y. Sung

DOI: https://doi.org/10.1158/0008-5472.22395233

2023-01-01

Abstract:Supplementary Table 7 from EZH2-Mediated Concordant Repression of Wnt Antagonists Promotes β-Catenin–Dependent Hepatocarcinogenesis
Supplementary Table 1 from EZH2-Mediated Concordant Repression of Wnt Antagonists Promotes β-Catenin–Dependent Hepatocarcinogenesis

Alfred S.L. Cheng,Suki S. Lau,Yangchao Chen,Yutaka Kondo,May S. Li,Hai Feng,Arthur K. Ching,Kin F. Cheung,Hoi K. Wong,Joanna H. Tong,Hongchuan Jin,Kwong W. Choy,Jun Yu,Ka F. To,Nathalie Wong,Tim H.-M. Huang,Joseph J.Y. Sung

DOI: https://doi.org/10.1158/0008-5472.22395236.v1

2023-01-01

Abstract:Supplementary Table 1 from EZH2-Mediated Concordant Repression of Wnt Antagonists Promotes β-Catenin–Dependent Hepatocarcinogenesis
E2F8 is a Potential Therapeutic Target for Hepatocellular Carcinoma

Yi Lv,Jia Xiao,Jing Liu,Feiyue Xing

DOI: https://doi.org/10.7150/jca.18255

IF: 3.9

2017-01-01

Journal of Cancer

Abstract:E2F transcriptional factors are widely expressed in a number of tissues and organs, possessing many regulatory functions related to cellular proliferation, differentiation, DNA repair, cell-cycle and cell apoptosis.E2F8 is a recently identified member of the E2F family with a duplicated DNA-binding domain feature discriminated from E2F1-6, controlling gene expression in a dimerization partner-independent manner.It is indispensable for angiogenesis, lymphangiogenesis and embryonic development.Although E2F8 and E2F7 perform complementary and overlapping functions in many cell metabolisms, E2F8, but not E2F7, overexpresses remarkably in hepatocellular carcinoma (HCC) to facilitate the HCC occurrence and development via activating a E2F1/ Cyclin D1 signaling pathway to regulate the G1-to S-phase transition of cell cycle progression or transcriptionally suppressing CDK1 to induce hepatocyte polyploidization.It also involves closely a variety of cellular physiological functions and pathological processes, which may bring a new breakthrough for the treatment of certain diseases, especially the HCC.Here, we summarize the latest progress of E2F8 on its relevant functions and mechanisms as well as potential application.
E2F1 Transactivates IQGAP3 and Promotes Proliferation of Hepatocellular Carcinoma Cells Through IQGAP3-mediated PKC-alpha Activation.

Min Lin,Yiming Liu,Xiaokun Ding,Qinjian Ke,Jieyao Shi,Zewei Ma,Hongqian Gu,Haixi Wang,Chuanfeng Zhang,Chenxi Yang,Zejun Fang,Linfu Zhou,Ming Ye

2019-01-01

Abstract:For decades, E2F1 has been recognized as a retinoblastoma protein (RB) binding transcription factor that regulates the cell cycle. E2F1 binds preferentially to RB and accelerates the cell cycle in most cancer cells. However, it is thought that E2F1 modulates cell proliferation in other ways as well. Herein, it has been discovered that in pathological tissues derived from hepatocellular carcinoma (HCC) patients, E2F1 correlates positively with IQGAP3 and that both of these factors are highly expressed (N = 164, R = 0.6716). In addition, a high level of E2F1 or IQGAP3 predicted poor survival in HCC patients. Further study determined that E2F1 transactivates IQGAP3, the GTPase binding protein in MHCC-97H cells. Co-immunoprecipitation analysis indicated that IQGAP3 interacts with PKCδ and competitively inhibits the interaction between PKCδ and PKCα, resulting in phosphorylation of PKCα activation and promotion of cell proliferation. This study reveals that highly expressed E2F1 not only transactivates cell-cycle-related factors but also promotes HCC proliferation by activating the phosphorylation of PKCα.
Supplemental Figure S5 from Histone Deacetylase HDAC8 Promotes Insulin Resistance and Β-Catenin Activation in NAFLD-Associated Hepatocellular Carcinoma

Ye Tian,Vincent W. S. Wong,Grace L.H. Wong,Weiqin Yang,Hanyong Sun,Jiayun Shen,Joanna H.M. Tong,Minnie Y.Y. Go,Yu-San Cheung,Paul B.S. Lai,Mi Zhou,Gang Xu,Tim H.‐M. Huang,Yuanyuan Wang,Ka Fai To,Alfred S.L. Cheng,Henry Lik‐Yuen Chan

DOI: https://doi.org/10.1158/0008-5472.22412076

2023-01-01

Abstract:HDAC8 promotes growth and inhibits apoptosis of HCC cells.
E2F4 Promotes the Proliferation of Hepatocellular Carcinoma Cells through Upregulation of CDCA3

Junye Liu,Lulu Xia,Shilei Wang,Xuefei Cai,Xiaoli Wu,Chunhong Zou,Baoju Shan,Miao Luo,Deqiang Wang

DOI: https://doi.org/10.7150/jca.53708

IF: 3.9

2021-01-01

Journal of Cancer

Abstract:Liver cancer, the second most commonly diagnosed cancer, is associated with high mortality rates. E2F4 is a member of the E2F transcription factor family. There are limited studies on the role of E2F4 in hepatocellular carcinoma (HCC). In this study, the expression of E2F4 in HCC tissue samples and cell lines was analyzed using quantitative real-time polymerase chain reaction. E2F4 expression positively correlated with tumor size in patients with HCC. Additionally, E2F4 expression was greater in HCC cells than in normal LO2 cells. Furthermore, overexpression of E2F4 significantly enhanced the proliferation, migration, and invasion of HCC cells. The results of a luciferase assay revealed that E2F4 upregulated the expression of CDCA3 by binding to its promoter region (1863'-ACGCGCGAGAATG-1875') and consequently promoted proliferation and cell cycle progression of HCC cells. Taken together, these results demonstrated that E2F4 might play a vital role in HCC progression and could serve as a potential biomarker for the diagnosis and as a therapeutic target of HCC.

oncology
Carcinogenesis Effects of E2F Transcription Factor 8 (E2F8) in Hepatocellular Carcinoma Outcomes: an Integrated Bioinformatic Report

Ying Lu,Jing Zhang,Lei Li,Shun Li,Zongguo Yang

DOI: https://doi.org/10.1042/bsr20193212

2020-01-01

Bioscience Reports

Abstract:This report aimed to investigate the carcinogenesis effects of E2F transcription factor 8 (E2F8) in hepatocellular carcinoma (HCC). E2F8 expression level was compared in Gene Expression Omnibus (GEO), The Cancer Genome Atlas (TCGA) and Oncomine. Survival analysis of E2F8 for HCC were conducted in Kaplan–Meier plotter. Correlations of E2F8 and clinico-pathological features were performed in TCGA. Enrichment of interacted and similar genes with E2F8 was evaluated in Gene Set Enrichment Analysis (GSEA) and Metascape. We found that E2F8 was significantly up-regulated in tumor tissues compared with nontumor tissues (all P < 0.01). Moreover, E2F8 was significantly overexpressed in peripheral blood mononuclear cell (PBMC) in HCC patients than that in healthy individuals (P < 0.001). Meta-analysis in Oncomine database confirmed that E2F8 was significantly higher in HCC tumors (P = 4.28E-08). Additionally, E2F8 elevation significantly correlated with overall survival (OS), recurrence-free survival (RFS), disease-specific survival (DSS) and progression-free survival (PFS) in HCC patients (all P < 0.01). E2F8 level was significantly higher in HCC patients with advanced neoplasm histologic grade, American Joint Committee on Cancer (AJCC) stage and α-fetoprotein (AFP) elevation (all P < 0.05). Cox regression model demonstrated that high E2F8 was an independent risk factor for OS and DFS in HCC patients (HR = 2.16, P = 0.003 and HR = 1.64, P = 0.002, respectively). Enrichment analysis revealed that genes interacted/similar with E2F8 were mainly enriched in cell cycle pathways/biological process. Conclusively, up-regulated in tumors, E2F8 might accelerate tumor progression and result in unfavorable outcomes in HCC patients.

Supplementary Figure 5 from E2F8 Contributes to Human Hepatocellular Carcinoma Via Regulating Cell Proliferation

Supplementary Figure 6 from E2F8 Contributes to Human Hepatocellular Carcinoma Via Regulating Cell Proliferation

Supplementary Figure 7 from E2F8 Contributes to Human Hepatocellular Carcinoma Via Regulating Cell Proliferation

Supplementary Figure 4 from E2F8 Contributes to Human Hepatocellular Carcinoma Via Regulating Cell Proliferation

Supplementary Figure 3 from E2F8 Contributes to Human Hepatocellular Carcinoma via Regulating Cell Proliferation

Supplementary Figure Legends 1-7 from E2F8 Contributes to Human Hepatocellular Carcinoma Via Regulating Cell Proliferation

Supplementary Tables 1-2 from E2F8 Contributes to Human Hepatocellular Carcinoma via Regulating Cell Proliferation

Data from E2F8 Contributes to Human Hepatocellular Carcinoma via Regulating Cell Proliferation

Supplementary Methods, Figures 1-4 from Rho Kinase Phosphorylation Promotes Ezrin-Mediated Metastasis in Hepatocellular Carcinoma

Supplementary Figure from HMGN5 Escorts Oncogenic STAT3 Signaling by Regulating the Chromatin Landscape in Breast Cancer Tumorigenesis

Supplementary Methods, Figures 1-9, Tables 2-6 from EZH2-Mediated Concordant Repression of Wnt Antagonists Promotes Β-Catenin–dependent Hepatocarcinogenesis

Supplementary Data from HBx-Induced HSPA8 Stimulates HBV Replication and Suppresses Ferroptosis to Support Liver Cancer Progression

Supplementary Table 7 from EZH2-Mediated Concordant Repression of Wnt Antagonists Promotes Β-Catenin–dependent Hepatocarcinogenesis

Supplementary Table 1 from EZH2-Mediated Concordant Repression of Wnt Antagonists Promotes β-Catenin–Dependent Hepatocarcinogenesis

E2F8 is a Potential Therapeutic Target for Hepatocellular Carcinoma

E2F1 Transactivates IQGAP3 and Promotes Proliferation of Hepatocellular Carcinoma Cells Through IQGAP3-mediated PKC-alpha Activation.

Supplemental Figure S5 from Histone Deacetylase HDAC8 Promotes Insulin Resistance and Β-Catenin Activation in NAFLD-Associated Hepatocellular Carcinoma

E2F4 Promotes the Proliferation of Hepatocellular Carcinoma Cells through Upregulation of CDCA3

Carcinogenesis Effects of E2F Transcription Factor 8 (E2F8) in Hepatocellular Carcinoma Outcomes: an Integrated Bioinformatic Report